Analysis of Phenotypic Variables and Differentiation Between Untypical Crohn’s Disease and Untypical Intestinal Tuberculosis
- 11 Downloads
The differentiation between untypical intestinal tuberculosis (UITB) and untypical Crohn’s disease (UCD) is a challenge.
To analyze phenotypic variables and propose a novel prediction model for differential diagnosis of two conditions.
A total of 192 patients were prospectively enrolled. The clinical, laboratory, endoscopic, and radiological features were investigated and subjected to univariable and multivariable analyses. The final prediction model for differentiation between UCD and UITB was developed by logistic regression analysis and Fisher discriminant analysis on the training set. The same discriminant function was tested on the validation set.
Twenty-five candidates were selected from 52 phenotypic variables of typical Crohn’s disease (TCD), UCD, and UITB patients. UCD’s variables overlapped with both TCD and UITB. The percentages of tuberculosis history, positive PPD, and positive T-SPOT result in UCD were all significantly higher than that in TCD (11.6% vs. 0.0%, 27.9% vs. 0.0%, 25.6% vs. 4.5%, respectively, P < 0.05). The regression equations and Fisher discriminant function for discrimination between UCD and UITB were developed. In the training data, the area under the receiver operating characteristic of equations was 0.834, 0.69, and 0.648 in the clinical-laboratory, endoscopic, and radiological model, respectively. The accuracy of Fisher discriminant function for discrimination was 86% in UCD and 73% in UITB in the validation data.
Phenotypes of UCD patients in TB-endemic countries may be associated with TB infection history. Fisher discriminant analysis is a good choice to differentiate UCD from UITB, which is worthy of verification in clinical practice.
KeywordsUntypical Crohn’s disease Intestinal tuberculosis Prediction model Fisher discriminant analysis
The authors thank all the participants and healthcare professionals for their contributions to this study.
This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81470801)
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 8.Molodecky NA, Soon IS, Rabi DM, et al. increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2011;142:e42.Google Scholar
- 9.Suk-Kyun Y, Sungcheol Y, Jin-Ho K, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Gastroenterology. 2008;124:A210-A.Google Scholar
- 10.Ng SC, Hirai HW, Tsoi KKF, et al. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn’s disease in Asians. J Gastroenterol Hepatol. 2015;29:1664–1670.CrossRefGoogle Scholar
- 19.Arie L, Sibylle K, Dan T, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795–806.Google Scholar
- 28.Chinese Society of Gastroenterology. Consensus on diagnosis and management of inflammatory Bowel disease (Guangzhou, 2012). Chin J Dig. 2012;32:796–813. https://doi.org/10.3760/cma.j.issn.0254-1432.2012.12.002.Google Scholar
- 29.Zhang T, Fan R, Wang Z, et al. Differential diagnosis between Crohn’s disease and intestinal tuberculosis using integrated parameters including clinical manifestations, T-SPOT, endoscopy and CT enterography. Int J Clin Exp Med. 2014;8:17578–17589.Google Scholar